Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

HIV Infection

Free Subscription 26.02.2024 1 AIDS 6 AIDS Res Hum Retroviruses 1 Antimicrob Agents Chemother 1 Antivir Ther 2 BMC Cancer 1 Cell 1 Clin Infect Dis 3 HIV Med 1 Int J Dermatol 1 J Acquir Immune Defic Syndr 1 J Clin Invest 3 J Infect Dis 3 J Med Virol 1 J Virol 1 Lancet 1 Lancet Infect Dis 2 PLoS Med 8 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. DEVENDRA A, Kohler M, Letsika M, Khooa H, et al
   HIV viral suppression in children and adolescents two years after transition to dolutegravir: a multicentre cohort study.
   AIDS. 2024 Jan 10. doi: 10.1097/QAD.0000000000003835.
   PubMed         Abstract available
   
   

   
   AIDS Res Hum Retroviruses

2. LAUFER N, Bouzas MB, Fernandez-Giuliano S, Zapiola I, et al
   Pretreatment HIV-1 Resistance in Argentina: results from the second surveillance study following WHO guidelines (2019).
   AIDS Res Hum Retroviruses. 2024 Feb 22. doi: 10.1089/AID.2023.0083.
   PubMed         Abstract available
   
   
3. XU K, Chen J, Zhu M, Zhang X, et al
   Exploring HIV-1 transmission features among older individuals in developed eastern China.
   AIDS Res Hum Retroviruses. 2024 Feb 22. doi: 10.1089/AID.2023.0066.
   PubMed         Abstract available
   
   
4. DUBE K, Perez-Brumer A, Patel H, Zhou C, et al
   "This is actually a really unique moment in time": Navigating Long-Acting HIV Treatment and HIV Cure Research with Analytical Treatment Interruptions - A Qualitative Interview Study in the United States.
   AIDS Res Hum Retroviruses. 2024 Feb 22. doi: 10.1089/AID.2023.0105.
   PubMed         Abstract available
   
   
5. GULER E, Arikan Sarioglu A, Sultanoglu N, Suer K, et al
   Molecular Epidemiology of HIV-1 Subtypes and Primary Antiretroviral Resistance Profiles in Northern Cyprus: First Data Series.
   AIDS Res Hum Retroviruses. 2024 Feb 17. doi: 10.1089/AID.2023.0021.
   PubMed         Abstract available
   
   
6. KHAYUMBI J, Sasser L, McLaughlin T, Muchiri B, et al
   Active tuberculosis is associated with depletion of HIV-specific CD4 and CD8 T cells in people with HIV.
   AIDS Res Hum Retroviruses. 2024 Feb 17. doi: 10.1089/AID.2023.0088.
   PubMed         Abstract available
   
   
7. SACHDEVA RK, Naidu G, Chauhan P, Kharbanda S, et al
   CSF viral escape on HAART: Analysis from single tertiary care centre.
   AIDS Res Hum Retroviruses. 2024 Feb 17. doi: 10.1089/AID.2022.0187.
   PubMed         Abstract available
   
   

   
   Antimicrob Agents Chemother

8. MULATO A, Lansdon E, Aoyama R, Voigt J, et al
   Preclinical characterization of a non-peptidomimetic HIV protease inhibitor with improved metabolic stability.
   Antimicrob Agents Chemother. 2024 Feb 21:e0137323. doi: 10.1128/aac.01373.
   PubMed         Abstract available
   
   

   
   Antivir Ther

9. LEPIK KJ, Hunt OL, Bacani N, Wang L, et al
   Adverse drug reactions attributed to generic substitution of antiretroviral medications among HIV treatment and pre-exposure prophylaxis clients in British Columbia, Canada.
   Antivir Ther. 2024;29:13596535241233128.
   PubMed         Abstract available
   
   

   
   BMC Cancer

10. TAN R, Zhu X, Sun Y, Yang S, et al
    The association of HBV infection and head and neck cancer: a systematic review and meta-analysis.
    BMC Cancer. 2024;24:225.
    PubMed         Abstract available
    
    
11. NAKIGOZI H, Ndejjo R, Bazeyo W, Nabaggala A, et al
    Prevalence of genital high-risk human papillomavirus infections and associated factors among women living with human immunodeficiency virus in Uganda.
    BMC Cancer. 2024;24:243.
    PubMed         Abstract available
    
    

    
    Cell

12. ARMANI-TOURRET M, Gao C, Hartana CA, Sun W, et al
    Selection of epigenetically privileged HIV-1 proviruses during treatment with panobinostat and interferon-alpha2a.
    Cell. 2024 Feb 16:S0092-8674(24)00105-3. doi: 10.1016/j.cell.2024.
    PubMed         Abstract available
    
    

    
    Clin Infect Dis

13. AGGARWAL NR, Nordwall J, Braun DL, Chung L, et al
    Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19.
    Clin Infect Dis. 2024 Feb 20:ciad780. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    HIV Med

14. KLEEBAYOON A, Wiwanitkit V
    Asymptomatic monkeypox infection and highly sexually active MSM population.
    HIV Med. 2024 Feb 20. doi: 10.1111/hiv.13623.
    PubMed        
    
    
15. RAMOS-RUPERTO L, Arcos-Rueda MDM, de Miguel-Buckley R, Busca-Arenzana C, et al
    Sex differences in the effectiveness and tolerability of dolutegravir plus rilpivirine as a switch strategy in people living with HIV.
    HIV Med. 2024 Feb 20. doi: 10.1111/hiv.13617.
    PubMed         Abstract available
    
    
16. HOLROYD KB, Han WM, Apornpong T, Trautmann L, et al
    Framingham risk score based vascular outcomes in acute versus chronic HIV cohorts after 6 years of ART.
    HIV Med. 2024 Feb 21. doi: 10.1111/hiv.13621.
    PubMed         Abstract available
    
    

    
    Int J Dermatol

17. TYAGI M, Verma V, Bhari N, Gupta S, et al
    Herpes presenting as pyoderma gangrenosum-like ulcers in a child with AIDS.
    Int J Dermatol. 2024;63:371-373.
    PubMed        
    
    

    
    J Acquir Immune Defic Syndr

18. GRIESEL R, Banda CG, Zhao Y, Omar Z, et al
    PHARMACOKINETICS OF SINGLE VERSUS DOUBLE-DOSE DOLUTEGRAVIR AFTER SWITCHING FROM A FAILING EFAVIRENZ-BASED REGIMEN.
    J Acquir Immune Defic Syndr. 2024 Feb 15. doi: 10.1097/QAI.0000000000003402.
    PubMed         Abstract available
    
    

    
    J Clin Invest

19. GASCA-CAPOTE C, Lian X, Gao C, Roseto IC, et al
    The HIV-1 reservoir landscape in persistent elite controllers and transient elite controllers.
    J Clin Invest. 2024 Feb 20:e174215. doi: 10.1172/JCI174215.
    PubMed         Abstract available
    
    

    
    J Infect Dis

20. PIHL RMF, Smith-Mahoney EL, Olson A, Yuen RR, et al
    Distinct subsets of Vdelta1 effector and Vdelta2 gammadelta T cells shift in frequency and are linked to plasma inflammatory markers during ART-suppressed HIV infection.
    J Infect Dis. 2024 Feb 23:jiae091. doi: 10.1093.
    PubMed         Abstract available
    
    
21. THIELE RJ, Grunhagel B, Muenchhoff M, Pujantell-Graell M, et al
    Magnitude of Type I Interferon Responses by Plasmacytoid Dendritic Cells After TLR7 Stimulation Is Associated With Human Immunodeficiency Virus Type 1 (HIV-1) Reservoir Sizes in Cisgender Women With HIV-1 on Antiretroviral Therapy.
    J Infect Dis. 2024 Feb 22:jiae013. doi: 10.1093.
    PubMed         Abstract available
    
    
22. SHIAU S, Zumpano F, Wang Z, Shah J, et al
    Epigenetic Aging and Musculoskeletal Outcomes in a Cohort of Women Living With HIV.
    J Infect Dis. 2024 Feb 15:jiae016. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Med Virol

23. XU Y, Jiao K, Zhang Y, Huang S, et al
    Behavioral intentions of self-isolation and informing close contacts after developing mpox-related symptoms among young men who have sex with men in China.
    J Med Virol. 2024;96:e29470.
    PubMed         Abstract available
    
    
24. DEL PINO M, Vorsters A, Joura EA, Doorbar J, et al
    Risk factors for human papillomavirus infection and disease: A targeted literature summary.
    J Med Virol. 2024;96:e29420.
    PubMed         Abstract available
    
    
25. SERWIN K, Scheibe K, Urbanska A, Aksak-Was B, et al
    Phylodynamic evolution of HIV-1 A6 sub-subtype epidemics in Poland.
    J Med Virol. 2024;96:e29482.
    PubMed         Abstract available
    
    

    
    J Virol

26. FENTON AD, Archin N, Turner A-M, Joseph S, et al
    A novel high-throughput microwell outgrowth assay for HIV-infected cells.
    J Virol. 2024 Feb 20:e0179823. doi: 10.1128/jvi.01798.
    PubMed         Abstract available
    
    

    
    Lancet

27. JOHNSTONE F
    Picture an epidemic: contemporary culture and HIV.
    Lancet. 2024 Feb 13:S0140-6736(24)00252-6. doi: 10.1016/S0140-6736(24)00252.
    PubMed        
    
    

    
    Lancet Infect Dis

28. ALLAN-BLITZ LT, Fifer H, Klausner JD
    Managing treatment failure in Neisseria gonorrhoeae infection: current guidelines and future directions.
    Lancet Infect Dis. 2024 Feb 14:S1473-3099(24)00001.
    PubMed         Abstract available
    
    

    
    PLoS Med

29. SEMITALA FC, Kadota JL, Musinguzi A, Welishe F, et al
    Comparison of 3 optimized delivery strategies for completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV in Uganda: A single-center randomized trial.
    PLoS Med. 2024;21:e1004356.
    PubMed         Abstract available
    
    
30. MATHUR S, Smuk M, Evans C, Wedderburn CJ, et al
    Estimating the impact of alternative programmatic cotrimoxazole strategies on mortality among children born to mothers with HIV: A modelling study.
    PLoS Med. 2024;21:e1004334.
    PubMed         Abstract available
    
    

    
    PLoS One

31. RUNGMAITREE S, Werarak P, Pumpradit W, Phongsamart W, et al
    A pilot program of HIV pre-exposure prophylaxis in Thai youth.
    PLoS One. 2024;19:e0298914.
    PubMed         Abstract available
    
    
32. MUDRA RAKSHASA-LOOTS A, Naidoo S, Hamana T, Fanqa B, et al
    Multi-modal analysis of inflammation as a potential mediator of depressive symptoms in young people with HIV: The GOLD depression study.
    PLoS One. 2024;19:e0298787.
    PubMed         Abstract available
    
    
33. LIKOTI PG, Kuupiel D, Khuzwayo N
    Mapping factors influencing initiation of antiretroviral treatment among adolescents living with HIV/AIDS in sub-Saharan Africa: A scoping review protocol.
    PLoS One. 2024;19:e0289515.
    PubMed         Abstract available
    
    
34. MESIC A, Decroo T, Mar HT, Jacobs BKM, et al
    Correction: Viraemic-time predicts mortality among people living with HIV on second-line antiretroviral treatment in Myanmar: A retrospective cohort study.
    PLoS One. 2024;19:e0299460.
    PubMed         Abstract available
    
    
35. NYMAN F
    Reshaping the narrative: Tracing the historical trajectory of HIV/AIDS, gay men, and public health in Sweden.
    PLoS One. 2024;19:e0298630.
    PubMed         Abstract available
    
    
36. KAMAU SG, Akatusasira R, Namatovu A, Kibet E, et al
    The level of antiretroviral therapy (ART) adherence among orphan children and adolescents living with HIV/AIDS: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0295227.
    PubMed         Abstract available
    
    
37. STANTON AM, Boyd RL, O'Cleirigh C, Olivier S, et al
    HIV, multimorbidity, and health-related quality of life in rural KwaZulu-Natal, South Africa: A population-based study.
    PLoS One. 2024;19:e0293963.
    PubMed         Abstract available
    
    
38. CONAN N, Simons E, Chihana ML, Ohler L, et al
    Correction: Increase in HIV viral suppression in KwaZulu-Natal, South Africa: Community-based cross sectional surveys 2018 and 2013. What remains to be done?
    PLoS One. 2024;19:e0299408.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.